A Comparative Analysis of Individual RAS Mutations in Cancer Biology
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Comparative Analysis of Individual RAS Mutations in Cancer Biology
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-10-18
DOI
10.3389/fonc.2019.01088
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Integrated Global Analysis of Compartmentalized HRAS Signaling
- (2019) Tapesh Santra et al. Cell Reports
- Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRASG13D mutation
- (2019) Theodosia Charitou et al. BRITISH JOURNAL OF CANCER
- Tissue-Specific Oncogenic Activity of KRASA146T
- (2019) Emily J. Poulin et al. Cancer Discovery
- G12V and G12C mutations in the gene KRAS are associated with a poorer prognosis in primary colorectal cancer
- (2019) Tamuro Hayama et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Role of protein kinase CK2 in antitumor drug resistance
- (2019) Christian Borgo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- RAS-mediated oncogenic signaling pathways in human malignancies
- (2018) Abdul Q. Khan et al. SEMINARS IN CANCER BIOLOGY
- KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non–small-cell Lung Cancer
- (2018) Stéphane Renaud et al. Clinical Lung Cancer
- KRASmutation coupled withp53loss is sufficient to induce ovarian carcinosarcomas in mice
- (2017) Feng-Hsiang Tang et al. INTERNATIONAL JOURNAL OF CANCER
- RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer
- (2017) Chao Yan et al. PHARMACOLOGICAL REVIEWS
- Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells
- (2016) Christian Posch et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma
- (2016) Sophia Doll et al. MOLECULAR & CELLULAR PROTEOMICS
- KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
- (2016) Barbara Bournet et al. Clinical and Translational Gastroenterology
- Comparative metabolomics profiling of isogenic KRAS wild type and mutant NSCLC cells in vitro and in vivo
- (2016) Laura Brunelli et al. Scientific Reports
- Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations
- (2015) Dean E. Hammond et al. JOURNAL OF PROTEOME RESEARCH
- Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer
- (2015) Wouter W. Mellema et al. LUNG CANCER
- Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations
- (2015) J. C. Hunter et al. MOLECULAR CANCER RESEARCH
- KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells
- (2015) Dominic Leiser et al. Molecular Oncology
- G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab
- (2015) Ondrej Fiala et al. TUMOR BIOLOGY
- Comparative analysis of KRAS codon 12, 13, 18, 61 and 117 mutations using human MCF10A isogenic cell lines
- (2015) Britta Stolze et al. Scientific Reports
- Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXR
- (2015) Linara Gabitova et al. Cell Reports
- Association Between Specific Mutations inKRASCodon 12 and Colorectal Liver Metastasis
- (2015) Georgios Antonios Margonis et al. JAMA Surgery
- Clinically relevant genes and regulatory pathways associated with NRASQ61 mutations in melanoma through an integrative genomics approach
- (2015) Wei Jiang et al. Oncotarget
- Capturing the metabolomic diversity of KRAS mutants in non-small-cell lung cancer cells
- (2015) Laura Brunelli et al. Oncotarget
- Molecular Pathways: Targeting RAC-p21-Activated Serine-Threonine Kinase Signaling in RAS-Driven Cancers
- (2014) N. M. Baker et al. CLINICAL CANCER RESEARCH
- Cholesterol and Cancer, in the Balance
- (2014) S. Silvente-Poirot et al. SCIENCE
- Mutation-Specific RAS Oncogenicity Explains NRAS Codon 61 Selection in Melanoma
- (2014) C. E. Burd et al. Cancer Discovery
- KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer
- (2013) Stefan Boeck et al. JOURNAL OF GASTROENTEROLOGY
- KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials
- (2013) Fausto Petrelli et al. MEDICAL ONCOLOGY
- The Role of the PI3K-AKT Pathway in Melanoma
- (2012) Michael A. Davies CANCER JOURNAL
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- Association ofKRASG13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab
- (2012) Sabine Tejpar et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
- (2012) Nathan T. Ihle et al. JNCI-Journal of the National Cancer Institute
- Dclk1 distinguishes between tumor and normal stem cells in the intestine
- (2012) Yuki Nakanishi et al. NATURE GENETICS
- A KrasG12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis
- (2011) C A Whipple et al. ONCOGENE
- Carbon metabolism and the sign of control coefficients in metabolic adaptations underlying K-ras transformation
- (2010) Pedro de Atauri et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
- (2010) G Smith et al. BRITISH JOURNAL OF CANCER
- Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer
- (2010) M. Janakiraman et al. CANCER RESEARCH
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
- (2010) Wendy De Roock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Control of Cell Survival and Proliferation by Mammalian Eukaryotic Initiation Factor 4B
- (2010) D. Shahbazian et al. MOLECULAR AND CELLULAR BIOLOGY
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
- (2009) Ji Luo et al. CELL
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients
- (2008) J. W. Tyner et al. BLOOD
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
- (2008) Kevin M Haigis et al. NATURE GENETICS
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Distinct functions of H-Ras and K-Ras in proliferation and survival of primary hepatocytes due to selective activation of ERK and PI3K
- (2007) Carola M. Rosseland et al. JOURNAL OF CELLULAR PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started